Vicarious Surgical Inc. (RBOT): Price and Financial Metrics
RBOT Price/Volume Stats
| Current price | $2.20 | 52-week high | $4.76 |
| Prev. close | $2.20 | 52-week low | $1.36 |
| Day low | $2.18 | Volume | 187,100 |
| Day high | $2.28 | Avg. volume | 334,812 |
| 50-day MA | $2.16 | Dividend yield | N/A |
| 200-day MA | $2.88 | Market Cap | 279.17M |
RBOT Stock Price Chart Interactive Chart >
Vicarious Surgical Inc. (RBOT) Company Bio
Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Latest RBOT News From Around the Web
Below are the latest news stories about VICARIOUS SURGICAL INC that investors may wish to consider to help them evaluate RBOT as an investment opportunity.
Vicarious Surgical Announces Promotion of John Mazzola to Chief Operating OfficerWALTHAM, Mass., May 18, 2023--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced the promotion of John Mazzola to Chief Operating Officer. |
Vicarious Surgical Reports First Quarter 2023 Financial ResultsWALTHAM, Mass., May 08, 2023--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results for the quarter ended March 31, 2023. Management will host a corresponding conference call at 4:30 p.m. ET today, May 8, 2023. |
Vicarious Surgical Earns Recognition from Fast Company and MedTech Breakthrough AwardsWALTHAM, Mass., May 04, 2023--Vicarious Surgical, Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced that the company earned recognition from Fast Company and the MedTech Breakthrough Awards for two industry awards: |
Vicarious Surgical to Report First Quarter 2023 Financial Results on May 8, 2023WALTHAM, Mass., April 24, 2023--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the first quarter ended March 31, 2023, after the market closes on Monday, May 8, 2023. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. |
Vicarious Surgical to Participate in Upcoming ConferencesWALTHAM, Mass., February 22, 2023--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced that the company will be participating in the following upcoming investor conferences. |
RBOT Price Returns
| 1-mo | 1.85% |
| 3-mo | -16.67% |
| 6-mo | -21.71% |
| 1-year | -51.22% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | 8.91% |
| 2022 | -80.98% |
| 2021 | 4.53% |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
Loading social stream, please wait...